https://www.selleckchem.com/pr....oducts/Nafamostat-me
Our study was to investigate the value of pretreatment F-FDG uptake heterogeneity to predict the prognosis of patients with locally recurrent nasopharyngeal carcinoma (LRNPC) treated by carbon ion radiotherapy (CIRT). Twenty-nine LRNPC patients who underwent whole-body F-FDG PET/CT scanning before CIRT were enrolled. Heterogeneity index (HI)-based F-FDG uptake, and the PET/CT traditional parameters, including SUVmax, MTV, and TLG were assessed. Receiver operator characteristics (ROC) determined the best cutoff value, and loc
Like
Comment
Share
